Prominent role of histone lysine demethylases in cancer epigenetics and therapy

Avilala Janardhan; Chandrasekhar Kathera; Amrutha Darsi; Wajid Ali; Lingfeng He; Yanhua Yang; Libo Luo; Zhigang Guo

doi:10.18632/oncotarget.24319

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Prominent role of histone lysine demethylases in cancer epigenetics and therapy

Avilala Janardhan, Chandrasekhar Kathera, Amrutha Darsi, Wajid Ali, Lingfeng He, Yanhua Yang, Libo Luo _ and Zhigang Guo

PDF | HTML | How to cite

Oncotarget. 2018; 9:34429-34448. https://doi.org/10.18632/oncotarget.24319

Metrics: PDF 1857 views | HTML 3611 views | ?

Abstract

Avilala Janardhan1,2, Chandrasekhar Kathera2, Amrutha Darsi2, Wajid Ali2, Lingfeng He2, Yanhua Yang1, Libo Luo1 and Zhigang Guo2

1The No. 7 People’s Hospital of Changzhou, Changzhou, China

2Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China

Correspondence to:

Libo Luo, email: [email protected]

Zhigang Guo, email: [email protected]

Keywords: epigenetics; histone modifications; protein methylation; lysine specific demethylases; therapeutics

Received: November 11, 2017 Accepted: December 04, 2017 Epub: January 25, 2018 Published: September 28, 2018

ABSTRACT

Protein methylation has an important role in the regulation of chromatin, gene expression and regulation. The protein methyl transferases are genetically altered in various human cancers. The enzymes that remove histone methylation have led to increased awareness of protein interactions as potential drug targets. Specifically, Lysine Specific Demethylases (LSD) removes methylated histone H3 lysine 4 (H3K4) and H3 lysine 9 (H3K9) through formaldehyde-generating oxidation. It has been reported that LSD1 and its downstream targets are involved in tumor-cell growth and metastasis. Functional studies of LSD1 indicate that it regulates activation and inhibition of gene transcription in the nucleus. Here we made a discussion about the summary of histone lysine demethylase and their functions in various human cancers.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24319

Publication Alerts

Reviews:

Prominent role of histone lysine demethylases in cancer epigenetics and therapy

Abstract